| NDC包装代码 | 产品NDC | 产品类型 | 商品名 | 通用名 | 剂型 | 给药途径 | 上市日期 | 结束日期 | 市场类别 | 申请号 | 标签持有者 | 活性成分 | 规格 | 包装描述 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 67877-279-33 | 67877-279 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201113 | N/A | ANDA | ANDA203740 | Ascend Laboratories, LLC | TACROLIMUS | 1 mg/1 | 50 BLISTER PACK in 1 CARTON (67877-279-33) / 1 CAPSULE in 1 BLISTER PACK |
| 67877-280-01 | 67877-280 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201113 | N/A | ANDA | ANDA203740 | Ascend Laboratories, LLC | TACROLIMUS | 5 mg/1 | 100 CAPSULE in 1 BOTTLE (67877-280-01) |
| 67877-280-33 | 67877-280 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201113 | N/A | ANDA | ANDA203740 | Ascend Laboratories, LLC | TACROLIMUS | 5 mg/1 | 50 BLISTER PACK in 1 CARTON (67877-280-33) / 1 CAPSULE in 1 BLISTER PACK |
| 67877-279-01 | 67877-279 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201113 | N/A | ANDA | ANDA203740 | Ascend Laboratories, LLC | TACROLIMUS | 1 mg/1 | 100 CAPSULE in 1 BOTTLE (67877-279-01) |
| 67877-278-33 | 67877-278 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201113 | N/A | ANDA | ANDA203740 | Ascend Laboratories, LLC | TACROLIMUS | .5 mg/1 | 50 BLISTER PACK in 1 CARTON (67877-278-33) / 1 CAPSULE in 1 BLISTER PACK |
| 67877-278-01 | 67877-278 | HUMAN PRESCRIPTION DRUG | Tacrolimus | Tacrolimus | CAPSULE | ORAL | 20201113 | N/A | ANDA | ANDA203740 | Ascend Laboratories, LLC | TACROLIMUS | .5 mg/1 | 100 CAPSULE in 1 BOTTLE (67877-278-01) |